Universal-Beteiligungs- und Servicegesellschaft’s Blueprint Medicines BPMC Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-41,571	Closed	-$5.33M	–	2101
2025 Q2	$5.33M	Sell	41,571 -43,209	-51%	-$4.49M	0.01%	810
2025 Q1	$7.5M	Buy	+84,780	New	+$8.27M	0.02%	657

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's BPMC Position: Q3 2025 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 41,571 shares — an estimated $5.33M sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in BPMC in Q1 2025 and held it in 2 quarters. The position peaked at $7.5M in Q1 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Universal-Beteiligungs- und Servicegesellschaft reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Universal-Beteiligungs- und Servicegesellschaft sold 41,571 Blueprint Medicines shares in Q3 2025, an estimated $5.33M.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Blueprint Medicines in Q1 2025 and held it in 2 quarters.
Universal-Beteiligungs- und Servicegesellschaft's Blueprint Medicines position peaked at $7.5M in Q1 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q3 2025, filed 30 Oct 2025.